000095755 001__ 95755 000095755 005__ 20210902121801.0 000095755 0247_ $$2doi$$a10.1136/bmjopen-2020-040253 000095755 0248_ $$2sideral$$a120193 000095755 037__ $$aART-2020-120193 000095755 041__ $$aeng 000095755 100__ $$aJansana, A. 000095755 245__ $$aUse of real-world data to study health services utilisation and comorbidities in long-term breast cancer survivors (the SURBCAN study): study protocol for a longitudinal population-based cohort study 000095755 260__ $$c2020 000095755 5060_ $$aAccess copy available to the general public$$fUnrestricted 000095755 5203_ $$aINTRODUCTION: Breast cancer has become a chronic disease due to survival improvement and the need to monitor the side effects of treatment and the disease itself. The aim of the SURBCAN study is to describe comorbidity, healthcare services use and adherence to preventive recommendations in long-term breast cancer survivors and to compare them with those in women without this diagnosis in order to improve and adapt the care response to this group of survivors. METHODS AND ANALYSIS: Population-based retrospective cohort study using real-world data from cancer registries and linked electronic medical records in five Spanish regions. Long-term breast cancer survivors diagnosed between 2000 and 2006 will be identified and matched by age and administrative health area with women without this diagnosis. Sociodemographic and clinical variables including comorbidities and variables on the use of health services between 2012 and 2016 will be obtained from databases in primary and hospital care. Health services use will be assessed through the annual number of visits to primary care professionals and to specialists and through annual imaging and laboratory tests. Factors associated with healthcare utilisation and comorbidities will be analysed using multilevel logistic regression models. Recruitment started in December 2018. ETHICS AND DISSEMINATION: This study was approved by the Ethics Committee of Parc de Salut Mar. The results of the study will be published in a peer-reviewed journal and will be presented at national and international scientific conferences and at patient associations. TRIAL REGISTRATION NUMBER: This protocol is registered in Clinical Trials.gov (identifier: NCT03846999). 000095755 536__ $$9info:eu-repo/grantAgreement/ES/ISCIII/PI15-00098$$9info:eu-repo/grantAgreement/ES/ISCIII/PI16-00244$$9info:eu-repo/grantAgreement/ES/REDISSEC/RD16-0001-0013 000095755 540__ $$9info:eu-repo/semantics/openAccess$$aby-nc$$uhttp://creativecommons.org/licenses/by-nc/3.0/es/ 000095755 590__ $$a2.692$$b2020 000095755 591__ $$aMEDICINE, GENERAL & INTERNAL$$b64 / 169 = 0.379$$c2020$$dQ2$$eT2 000095755 592__ $$a1.131$$b2020 000095755 593__ $$aMedicine (miscellaneous)$$c2020$$dQ1 000095755 655_4 $$ainfo:eu-repo/semantics/article$$vinfo:eu-repo/semantics/publishedVersion 000095755 700__ $$aDel Cura, I. 000095755 700__ $$aPrados-Torres, A. 000095755 700__ $$aSanz Cuesta, T. 000095755 700__ $$aPoblador-Plou, B. 000095755 700__ $$0(orcid)0000-0002-5440-1710$$aGimeno Miguel, A. 000095755 700__ $$aLanzuela, M. 000095755 700__ $$aIbañez, B. 000095755 700__ $$aTamayo, I. 000095755 700__ $$aMoreno-Iribas, C. 000095755 700__ $$aPadilla-Ruiz, M. 000095755 700__ $$aRedondo, M. 000095755 700__ $$aComas, M. 000095755 700__ $$aDomingo, L. 000095755 700__ $$aDíaz-Holgado, A. 000095755 700__ $$aSalamanca, F.J. 000095755 700__ $$aCastells, X. 000095755 700__ $$aSala, M. 000095755 700__ $$aSURBCAN, group 000095755 773__ $$g10, 9 (2020), e040253 [7 pp]$$pBMJ Open$$tBMJ open$$x2044-6055 000095755 8564_ $$s408169$$uhttps://zaguan.unizar.es/record/95755/files/texto_completo.pdf$$yVersión publicada 000095755 8564_ $$s172174$$uhttps://zaguan.unizar.es/record/95755/files/texto_completo.jpg?subformat=icon$$xicon$$yVersión publicada 000095755 909CO $$ooai:zaguan.unizar.es:95755$$particulos$$pdriver 000095755 951__ $$a2021-09-02-09:54:57 000095755 980__ $$aARTICLE